Yuben Moodley

5.6k total citations
90 papers, 3.4k citations indexed

About

Yuben Moodley is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Yuben Moodley has authored 90 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Pulmonary and Respiratory Medicine, 28 papers in Physiology and 11 papers in Surgery. Recurrent topics in Yuben Moodley's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (53 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (20 papers) and Sarcoidosis and Beryllium Toxicity Research (16 papers). Yuben Moodley is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (53 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (20 papers) and Sarcoidosis and Beryllium Toxicity Research (16 papers). Yuben Moodley collaborates with scholars based in Australia, United Kingdom and United States. Yuben Moodley's co-authors include Ursula Manuelpillai, George Kolios, Philip J. Thompson, Darryl A. Knight, Amelia K. Scaffidi, Chrishan S. Samuel, Robin J. McAnulty, Alan Trounson, Daniel Atienza and Michael F. Beers and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and American Journal of Clinical Nutrition.

In The Last Decade

Yuben Moodley

82 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuben Moodley Australia 30 1.8k 787 747 701 559 90 3.4k
Fernanda Ferreira Cruz Brazil 33 1.6k 0.9× 884 1.1× 751 1.0× 1.1k 1.6× 244 0.4× 123 3.4k
Kurt Hong United States 17 1.2k 0.6× 499 0.6× 524 0.7× 266 0.4× 784 1.4× 36 3.1k
Joseph A. Lasky United States 39 2.7k 1.5× 1.4k 1.8× 449 0.6× 342 0.5× 592 1.1× 109 4.7k
Christina E. Barkauskas United States 17 3.1k 1.7× 1.4k 1.8× 1.4k 1.8× 245 0.3× 320 0.6× 27 4.5k
Mitchell A. Olman United States 35 1.7k 0.9× 870 1.1× 322 0.4× 176 0.3× 411 0.7× 68 3.5k
Santos Castañeda Spain 38 1.0k 0.6× 1.1k 1.4× 722 1.0× 427 0.6× 303 0.5× 298 5.6k
Jeffrey C. Horowitz United States 38 2.6k 1.4× 1.9k 2.4× 790 1.1× 243 0.3× 530 0.9× 82 5.8k
Steven E. Mutsaers Australia 41 2.0k 1.1× 984 1.3× 1.3k 1.8× 157 0.2× 426 0.8× 78 4.5k
Mohammad Naimul Islam United States 17 1.1k 0.6× 1.4k 1.8× 714 1.0× 449 0.6× 230 0.4× 30 3.3k
Paquita Nurden France 49 1.1k 0.6× 1.3k 1.6× 1.9k 2.5× 999 1.4× 250 0.4× 174 9.3k

Countries citing papers authored by Yuben Moodley

Since Specialization
Citations

This map shows the geographic impact of Yuben Moodley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuben Moodley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuben Moodley more than expected).

Fields of papers citing papers by Yuben Moodley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuben Moodley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuben Moodley. The network helps show where Yuben Moodley may publish in the future.

Co-authorship network of co-authors of Yuben Moodley

This figure shows the co-authorship network connecting the top 25 collaborators of Yuben Moodley. A scholar is included among the top collaborators of Yuben Moodley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuben Moodley. Yuben Moodley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mackintosh, John A., Marc Sylva, Lucio Calandriello, et al.. (2026). Likelihood of Usual Interstitial Pneumonia: A Novel Approach to Prognosis for Pulmonary Fibrosis. Respirology.
2.
Tan, Dino B.A., Wendy A. Cooper, Helen E. Jo, et al.. (2025). Pre‐Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated Patients. Respirology. 30(6). 504–514. 2 indexed citations
3.
Yang, Nan, Francesco Federico, Stephen M. Humphries, et al.. (2025). Prognostication in patients with idiopathic pulmonary fibrosis using quantitative airway analysis from HRCT: a retrospective study. European Respiratory Journal. 66(4). 2500981–2500981.
4.
Moodley, Yuben. (2025). Interstitial lung abnormalities: challenges and opportunity. The Lancet Respiratory Medicine. 13(9). 776–778.
5.
Moodley, Yuben & John A. Mackintosh. (2025). A Comprehensive Review of Interstitial Lung Abnormalities. Respirology. 30(5). 385–397. 1 indexed citations
6.
Tan, Dino B.A., et al.. (2025). The role of epigenetic regulation in idiopathic pulmonary fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 330(1). L13–L32.
7.
Mackintosh, John A., Gregory J. Keir, Lauren Troy, et al.. (2024). Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision. Respirology. 29(2). 105–135. 26 indexed citations
8.
Bultijnck, Renée, Katarzyna Pogoda, Vesna Bjelic‐Radisic, et al.. (2024). PCR98 Establishing Thresholds for Clinical Importance for EORTC Questionnaire Modules for Eight Specific Groups of Cancer Patients. Value in Health. 27(12). S524–S524.
9.
Zheng, Qiang, Lucy Leigh, Barbara de Graaff, et al.. (2023). Long‐term exposure to low concentrations of air pollution and decline in lung function in people with idiopathic pulmonary fibrosis: Evidence from Australia. Respirology. 28(10). 916–924. 13 indexed citations
10.
Lee, Silvia, et al.. (2023). The role of the host-microbiome and metabolomics in sarcoidosis. American Journal of Physiology-Cell Physiology. 325(5). C1336–C1353. 6 indexed citations
11.
12.
Graaff, Barbara de, Julie A. Campbell, Petr Otáhal, et al.. (2021). The impact of idiopathic pulmonary fibrosis on health state utility values: evidence from Australia. Quality of Life Research. 30(9). 2615–2632. 6 indexed citations
13.
Jo, Helen E., Tamera J. Corte, Ian Glaspole, et al.. (2019). Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry. BMC Pulmonary Medicine. 19(1). 84–84. 22 indexed citations
14.
Beers, Michael F. & Yuben Moodley. (2017). When Is an Alveolar Type 2 Cell an Alveolar Type 2 Cell? A Conundrum for Lung Stem Cell Biology and Regenerative Medicine. American Journal of Respiratory Cell and Molecular Biology. 57(1). 18–27. 101 indexed citations
15.
Tan, Dino B.A., et al.. (2015). Levels of CMV-reactive antibodies correlate with the induction of CD28null T cells and systemic inflammation in chronic obstructive pulmonary disease (COPD). Cellular and Molecular Immunology. 13(4). 551–553. 25 indexed citations
16.
Bondonno, Catherine P., Alex H. Liu, Kevin D. Croft, et al.. (2015). Absence of an effect of high nitrate intake from beetroot juice on blood pressure in treated hypertensive individuals: a randomized controlled trial. American Journal of Clinical Nutrition. 102(2). 368–375. 82 indexed citations
17.
Ding, Hang, et al.. (2012). A mobile-health system to manage Chronic Obstructive Pulmonary Disease patients at home. PubMed. 2012. 2178–2181. 22 indexed citations
18.
Moodley, Yuben, Chrishan S. Samuel, Vijesh Vaghjiani, et al.. (2010). Human Amnion Epithelial Cell Transplantation Abrogates Lung Fibrosis and Augments Repair. American Journal of Respiratory and Critical Care Medicine. 182(5). 643–651. 166 indexed citations
19.
Moodley, Yuben, Daniel Atienza, Ursula Manuelpillai, et al.. (2009). Human Umbilical Cord Mesenchymal Stem Cells Reduce Fibrosis of Bleomycin-Induced Lung Injury. American Journal Of Pathology. 175(1). 303–313. 287 indexed citations
20.
Moodley, Yuben, Amelia K. Scaffidi, Neil L.A. Misso, et al.. (2004). Comparison of the morphological and biochemical changes in normal human lung fibroblasts and fibroblasts derived from lungs of patients with idiopathic pulmonary fibrosis during FasL‐induced apoptosis. The Journal of Pathology. 202(4). 486–495. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fernanda Ferreira Cruz Breakdown of academic impact, for papers by Kurt Hong Breakdown of academic impact, for papers by Joseph A. Lasky Breakdown of academic impact, for papers by Christina E. Barkauskas Breakdown of academic impact, for papers by Mitchell A. Olman Breakdown of academic impact, for papers by Santos Castañeda Breakdown of academic impact, for papers by Jeffrey C. Horowitz Breakdown of academic impact, for papers by Steven E. Mutsaers Breakdown of academic impact, for papers by Mohammad Naimul Islam Breakdown of academic impact, for papers by Paquita Nurden
Rankless by CCL
2026